AVR anteris technologies global corp.

Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial, page-57

  1. 932 Posts.
    lightbulb Created with Sketch. 215
    Missed it deep in the Application for Quotation notice.

    As announced in the Appendix 3B released on 26 October 2023, 2,000,000 shares are proposed to be issued. The first tranche of 1,539,150 shares were issued on 2 November 2023. The second tranche was revised to 125,000 shares and it is now planned that the remaining 335,850 shares will be issued on or before 15 December 2023 with the intention to close as soon as possible.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.91
Change
-0.210(3.43%)
Mkt cap ! $91.59M
Open High Low Value Volume
$6.01 $6.08 $5.85 $44.71K 7.43K

Buyers (Bids)

No. Vol. Price($)
1 857 $5.83
 

Sellers (Offers)

Price($) Vol. No.
$6.08 260 1
View Market Depth
Last trade - 15.51pm 26/06/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.